New study reveals molecular mechanism in Alzheimer’s disease

A research team at the Institute of Neurosciences of the University of Barcelona (UBneuro) has led a study describing a new molecular mechanism that affects RNA processing and alters the process of protein synthesis in the brains of Alzheimer’s patients.

Cantourage Group SE (von NuWays AG) – Biotech Investments

Original-Research: Cantourage Group SE – from NuWays AG Classification of NuWays AG to Cantourage Group SE Company Name: Cantourage Group SE ISIN: DE000A3DSV01 Reason for

May 29, 2024

PharmAla Launches Prescriber’s Portal for Medical Professionals Focused on MDMA Therapy | Psychedelic Invest

TORONTO, May 03, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research,

May 3, 2024

DNA data security requires robust protections, not rhetoric

The BIOSECURE Act, now rolling through Congress, aims to protect the DNA data of Americans from companies with perceived national security risks. That is a

July 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.